Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Oral Phenylephrine An “Ineffective” Replacement For PSE – Pharmacists

This article was originally published in The Tan Sheet

Executive Summary

Phenylephrine taken at the FDA-approved dose of 10 mg is "unlikely to provide relief of nasal congestion" and is less efficacious than pseudoephedrine, according to a letter to the editor in the July Journal of Allergy & Clinical Immunology.
Advertisement

Related Content

Waxman Renews Push For FDA Examination Of Phenylephrine Efficacy
Waxman Renews Push For FDA Examination Of Phenylephrine Efficacy
Waxman Renews Push For FDA Examination Of Phenylephrine Efficacy
Phenylephrine Efficacy Will Be Questioned In Citizen Petition
Phenylephrine Efficacy Will Be Questioned In Citizen Petition
Phenylephrine Efficacy Will Be Questioned In Citizen Petition
Waxman Seeks Phenylephrine NDAC Review; Cites Efficacy Concerns
Pseudoephedrine Will Be Behind The Counter Across The Country By October
Pseudoephedrine Will Be Behind The Counter Across The Country By October
Replacing Pseudoephedrine Easier Said Than Done, OTC Firms Find

Topics

Advertisement
UsernamePublicRestriction

Register

PS099614

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel